Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: ThromboGenics Ltd
Woman and Man Max 99 years
ThromboGenics Ltd
Update Il y a 4 ans
A randomised, sham-injection controlled, double-masked, ascending dose, dose range-finding trial of microplasmin intravitreal injection for non-surgical PVD induction for treatment of diabetic macular edema
To evaluate safety and preliminary efficacy of several doses of intravitreal microplasmin in patients with diabetic macular edema
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
ThromboGenics Ltd
Update Il y a 4 ans
AN OPEN-LABEL CLINICAL TRIAL OF INTRA-ARTERIAL MICROPLASMIN ADMINISTRATION IN PATIENTS WITH ACUTE INTRACRANIAL VERTEBROBASILAR ARTERY OCCLUSION
To evaluate the safety and the arterial recanalization potential of microplasmin when administered intra-arterially in patients with acute intracranial vertebrobasilar artery occlusion
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
ThromboGenics Ltd
Update Il y a 4 ans
A Multi-Centre, Double-Blind, Placebo-Controlled, Ascending-Dose, Clinical Trial of Intra-venous Microplasmin Administration in Patients with Acute Ischemic Stroke
To evaluate the safety and efficacy of microplasmin administered intravenously in patients with acute ischemic stroke
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
ThromboGenics Ltd
Update Il y a 4 ans
A Randomized, Sham-Injection Controlled, Double-Masked, Ascending-Dose, Dose-Range-Finding, Multicenter Trial of Microplasmin Intravitreal Injection for Non-Surgical PVD Induction for Treatment of Vitreomacular Traction
To evaluate the safety and preliminary efficacy of 4 doses of intravitreal microplasmin in patients with vitreomacular traction
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
ThromboGenics Ltd
Update Il y a 4 ans
A Dose-Escalation Clinical Trial of Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy for Vitreomacular Traction Maculopathy
To evaluate the safety and preliminary efficacy of two doses and several exposure times of intravitreal microplasmin in the setting of pars plana vitrectomy for vitreomacular traction maculopathy
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
ThromboGenics Ltd
Update Il y a 4 ans
An Open Label Clinical Trial of Microplasmin Administered via the Trellis-8 Infusion System for the Treatment of Acute Iliofemoral Deep Vein Thrombosis
The primary purpose of this study is to evaluate the safety and efficacy of microplasmin administration using the Trellis-8 Infusion System in patients with acute iliofemoral DVT. The primary obje...
Country
None
organs
None
Specialty
None
Closed trial
More information